Laura Housman (CAS’88, SPH’94,’25, Questrom’00)

Laura brings extensive expertise in strategy, evidence generation, reimbursement and pricing, patient communications, population health, and personalized medicine to drive access to innovation across healthcare.

Before joining Avalere Health as managing director of the Evidence and Strategy practice, Laura was chief commercial and operations officer of the diagnostic company Olaris. Prior to her work at Olaris, Laura developed and led a team developing novel real-world evidence, population health initiatives, and market access solutions for a broad range of diagnostic assays at Exact Sciences. In 2015, she founded Access Solutions Consulting, which serves an extensive network of pharmaceutical, medical device, and diagnostic companies. She also led the Market Access, Pricing and Health Economics & Outcomes Research group within Novartis Pharmaceutical Corporation’s global pharma/molecular diagnostics unit and was executive director of marketing for Charles River Laboratories, focused on the commercialization of its worldwide preclinical, first-in-human, and biopharmaceutical services. Additionally, Laura served as director of marketing for Genzyme Genetics, where she spearheaded marketing and commercialization strategies in support of managed care outreach.

In addition to her work within industry, Ms. Housman spent a decade leading health services evaluation, contracting, and provider profiling initiatives as a director within not-for-profit healthcare insurance plan BlueCross BlueShield of Massachusetts. Laura is also an active advisor on a number of industry and volunteer boards, including serving as a Merit Reviewer for the Patient-Centered Outcomes Research Initiative (PCORI).

Laura holds a Master of Public Health, Master of Business Administration, and bachelor’s degree in economics from Boston University. She is currently a candidate for Doctor of Public Health (DrPH) at Boston University.